ArticleAnnals of surgical oncology2026

Neoadjuvant Dual-Targeted HER2 Therapy and Neoadjuvant Chemo-Immunotherapy is Associated with Improved Nodal pCR and Reduced Axillary Surgery.

Saranya Prathibha et al.PubMed ↗Publisher ↗

No numbers read from the abstract.